FDA authorizes anti-viral pill for COVID-19, Louisiana receives limited supply

The U.S. Food and Drug Administration recently issued an Emergency Use Authorization for Pfizer’s Paxlovid (nirmatrelvir tablets and ritonavir tablets) - the first oral treatment for COVID-19.

Related Keywords

Louisiana ,United States , ,Louisiana Department Of Health ,Drug Administration ,Emergency Use Authorization ,Louisiana Department ,Use Authorization ,Covid 19 ,Fda ,Acadiana ,Anti Viral Pill ,Katc ,Limited Supply ,Pharmacies ,